Do next-generation sequencing results drive diagnostic and therapeutic decisions in MDS?

Blood Adv. 2019 Nov 12;3(21):3454-3460. doi: 10.1182/bloodadvances.2019000680.

Abstract

This article has a companion Point by Thol and Platzbecker.

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • High-Throughput Nucleotide Sequencing
  • Humans
  • Myelodysplastic Syndromes*